Skip to main content
Fig. 3 | Cancer Imaging

Fig. 3

From: Prognostic value of MRI volumetric parameters in non-small cell lung cancer patients after immune checkpoint inhibitor therapy: comparison with response assessment criteria

Fig. 3

Kaplan-Meier Curves of Patients with Progressive Disease (PD) Versus Nonprogressive Disease (non-PD) for Each of the Classification Criteria (A) mRECIST, (B), RANO-BM, and (C) iRANO-BM

mRECIST: modified Response Evaluation Criteria in Solid Tumors; RANO-BM: Response Assessment in Neuro-Oncology Brain Metastases; iRANO-BM: immunotherapy Response Assessment in Neuro-Oncology adjusted for Brain Metastases

Back to article page

Cancer Imaging

ISSN: 1470-7330

Contact us